ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,337, issued on Jan. 27, was assigned to SENJU PHARMACEUTICAL Co. LTD. (Osaka, Japan) and MOCHIDA PHARMACEUTICAL Co. LTD. (Tokyo).
"Pharmaceutical drug containing heterocyclidene acetamide derivative" was invented by Takeshi Tarui (Osaka, Japan) and Shinya Kobayashi (Osaka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a means for treating dry eye. This disclosure can provide: a composition for use in treating dry eye; and a use thereof. The composition includes (E)-2-(7-trifluoromethyl-chroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalene-1-yl)acetamide, a pharmaceutically acceptable salt thereof, or a solvate...